Abstract
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Journal of Immunology |
| Vol/bind | 180 |
| Udgave nummer | 1 |
| Sider (fra-til) | 426-37 |
| Antal sider | 11 |
| ISSN | 0022-1767 |
| Status | Udgivet - 2008 |
Bibliografisk note
Keywords: Animals; Antigens, CD8; Computational Biology; Cytotoxicity, Immunologic; Epitope Mapping; Epitopes, T-Lymphocyte; Female; HLA-A Antigens; Herpesvirus Vaccines; Humans; Male; Mice; Mice, Transgenic; Peptides; T-Lymphocytes, Cytotoxic; Viral Envelope ProteinsCitationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D. / Chentoufi, Aziz Alami; Zhang, Xiuli; Lamberth, Kasper; Dasgupta, Gargi; Bettahi, Ilham; Nguyen, Alex; Wu, Michelle; Zhu, Xiaoming; Mohebbi, Amir; Buus, Soren; Wechsler, Steven L; Nesburn, Anthony B; BenMohamed, Lbachir.
I: Journal of Immunology, Bind 180, Nr. 1, 2008, s. 426-37.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
}
TY - JOUR
T1 - HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D
AU - Chentoufi, Aziz Alami
AU - Zhang, Xiuli
AU - Lamberth, Kasper
AU - Dasgupta, Gargi
AU - Bettahi, Ilham
AU - Nguyen, Alex
AU - Wu, Michelle
AU - Zhu, Xiaoming
AU - Mohebbi, Amir
AU - Buus, Soren
AU - Wechsler, Steven L
AU - Nesburn, Anthony B
AU - BenMohamed, Lbachir
N1 - Keywords: Animals; Antigens, CD8; Computational Biology; Cytotoxicity, Immunologic; Epitope Mapping; Epitopes, T-Lymphocyte; Female; HLA-A Antigens; Herpesvirus Vaccines; Humans; Male; Mice; Mice, Transgenic; Peptides; T-Lymphocytes, Cytotoxic; Viral Envelope Proteins
PY - 2008
Y1 - 2008
N2 - Evidence obtained from both animal models and humans suggests that T cells specific for HSV-1 and HSV-2 glycoprotein D (gD) contribute to protective immunity against herpes infection. However, knowledge of gD-specific human T cell responses is limited to CD4+ T cell epitopes, with no CD8+ T cell epitopes identified to date. In this study, we screened the HSV-1 gD amino acid sequence for HLA-A*0201-restricted epitopes using several predictive computational algorithms and identified 10 high probability CD8+ T cell epitopes. Synthetic peptides corresponding to four of these epitopes, each nine to 10 amino acids in length, exhibited high-affinity binding in vitro to purified human HLA-A*0201 molecules. Three of these four peptide epitopes, gD53-61, gD70-78, and gD278-286, significantly stabilized HLA-A*0201 molecules on T2 cell lines and are highly conserved among and between HSV-1 and HSV-2 strains. Consistent with this, in 33 sequentially studied HLA-A*0201-positive, HSV-1-seropositive, and/or HSV-2-seropositive healthy individuals, the most frequent and robust CD8+ T cell responses, assessed by IFN-gamma ELISPOT, CD107a/b cytotoxic degranulation, and tetramer assays, were directed mainly against gD53-61, gD70-78, and gD278-286 epitopes. In addition, CD8+ T cell lines generated by gD53-61, gD70-78, and gD278-286 peptides recognized infected target cells expressing native gD. Lastly, CD8+ T cell responses specific to gD53-61, gD70-78, and gD278-286 epitopes were induced in HLA-A*0201 transgenic mice following ocular or genital infection with either HSV-1 or HSV-2. The functional gD CD8+ T cell epitopes described herein are potentially important components of clinical immunotherapeutic and immunoprophylactic herpes vaccines.
AB - Evidence obtained from both animal models and humans suggests that T cells specific for HSV-1 and HSV-2 glycoprotein D (gD) contribute to protective immunity against herpes infection. However, knowledge of gD-specific human T cell responses is limited to CD4+ T cell epitopes, with no CD8+ T cell epitopes identified to date. In this study, we screened the HSV-1 gD amino acid sequence for HLA-A*0201-restricted epitopes using several predictive computational algorithms and identified 10 high probability CD8+ T cell epitopes. Synthetic peptides corresponding to four of these epitopes, each nine to 10 amino acids in length, exhibited high-affinity binding in vitro to purified human HLA-A*0201 molecules. Three of these four peptide epitopes, gD53-61, gD70-78, and gD278-286, significantly stabilized HLA-A*0201 molecules on T2 cell lines and are highly conserved among and between HSV-1 and HSV-2 strains. Consistent with this, in 33 sequentially studied HLA-A*0201-positive, HSV-1-seropositive, and/or HSV-2-seropositive healthy individuals, the most frequent and robust CD8+ T cell responses, assessed by IFN-gamma ELISPOT, CD107a/b cytotoxic degranulation, and tetramer assays, were directed mainly against gD53-61, gD70-78, and gD278-286 epitopes. In addition, CD8+ T cell lines generated by gD53-61, gD70-78, and gD278-286 peptides recognized infected target cells expressing native gD. Lastly, CD8+ T cell responses specific to gD53-61, gD70-78, and gD278-286 epitopes were induced in HLA-A*0201 transgenic mice following ocular or genital infection with either HSV-1 or HSV-2. The functional gD CD8+ T cell epitopes described herein are potentially important components of clinical immunotherapeutic and immunoprophylactic herpes vaccines.
M3 - Journal article
C2 - 18097044
VL - 180
SP - 426
EP - 437
JO - Journal of Immunology
JF - Journal of Immunology
SN - 0022-1767
IS - 1
ER -